Skip Navigation

Details for High Impact Journal

Superfund Research Program

Journal of the National Cancer Institute (impact factor: 13.506)

2018

2015

  • Wild CP, Bucher JR, de Jong BW, Dillner J, von Gertten C, Groopman JD, Herceg Z, Holmes E, Holmila R, Olsen JH, Ringborg U, Scalbert A, Shibata T, Smith MT, Ulrich CM, Vineis P, McLaughlin J. 2015. Translational cancer research: balancing prevention and treatment to combat cancer globally. J Natl Cancer Inst 107(1):353. doi:10.1093/jnci/dju353 PMID:25515230 PMCID:PMC4334834

2010

  • Christensen BC, Smith A, Zheng S, Koestler DC, Houseman E, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR, Kelsey KT, Wiencke JK. 2010. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 103:143-153. doi:10.1093/jnci/djq497 PMID:21163902 PMCID:PMC3022619

2009

  • Baris D, Karagas MR, Verrill C, Johnson A, Andrew AS, Marsit CJ, Colt JS, Cherala S, Samanic C, Waddell R, Cantor KP, Schned AR, Rothman N, Lubin JH, Fraumeni JF, Hoover RN, Kelsey KT, Silverman DT, Schwenn M. 2009. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101(22):1553-1561. doi:10.1093/jnci/djp361 PMID:19917915 PMCID:PMC2778671

2007

  • Marshall G, Ferreccio Readi C, Yuan Y, Bates MN, Steinmaus CM, Selvin S, Liaw J, Smith AH. 2007. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99(12):920-928. doi:10.1093/jnci/djm004 PMID:17565158

2005

2003

  • Tsuneoka Y, Dalton TP, Miller ML, Clay CD, Shertzer HG, Talaska G, Medvedovic M, Nebert DW. 2003. 4-Aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice. J Natl Cancer Inst 95(16):1227-1237. doi:10.1093/jnci/djg025 PMID:12928348

2002

  • Feng Z, Hu W, Chen JX, Pao A, Li H, Rom WN, Hung M, Tang M. 2002. Carcinogen-DNA adducts are preferentially formed and poorly repaired at codon 12 of the K-ras gene, a mutation hotspot in lung cancers of cigarette smokers. J Natl Cancer Inst 90:1527-1536.
  • Feng Z, Hu W, Chen JX, Pao A, Li H, Rom WN, Hung M, Tang M. 2002. Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer. J Natl Cancer Inst 94(20):1527-1536. PMID:12381705
  • Moore LE, Smith AH, Eng C, Kalman DA, DeVries S, Bhargava V, Chew K, Moore DH, Ferreccio Readi C, Rey OA, Waldman FM. 2002. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 94(22):1688-1696. PMID:12441324

1999

  • Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. 1999. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 91(23):2032-2038. PMID:10580029
  • Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark EJ, Christiani DC. 1999. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 91(7):614-619. PMID:10451453

1998

  • Kelsey KT, Wiencke JK. 1998. Growing pains for the environmental genetics of breast cancer: observations on a study of the glutathione s-transferases. J Natl Cancer Inst 90:484-485. PMID:9539238
Back
to Top